Northwestern Mutual Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.7K	Buy	399 +12	+3%	+$2.6K	﹤0.01%	2289
2026 Q1	$65.4K	Buy	387 +17	+5%	+$2.94K	﹤0.01%	2342
2025 Q4	$67.6K	Sell	370 -102	-22%	-$14.2K	﹤0.01%	2286
2025 Q3	$57.3K	Buy	472 +66	+16%	+$7.43K	﹤0.01%	2270
2025 Q2	$42.4K	Buy	406 +24	+6%	+$2.54K	﹤0.01%	2320
2025 Q1	$44.6K	Hold	382	–	–	﹤0.01%	2218
2024 Q4	$32.3K	Buy	382 +37	+11%	+$3.4K	﹤0.01%	2342
2024 Q3	$31K	Buy	345 +10	+3%	+$873	﹤0.01%	2326
2024 Q2	$27K	Buy	+335	New	+$24.8K	﹤0.01%	2305

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northwestern Mutual Wealth Management's AXSM Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Axsome Therapeutics (AXSM) stake by 3.1% in Q2 2026, buying an estimated $2.6K and bringing the position to 399 shares worth $97.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Northwestern Mutual Wealth Management first reported a position in AXSM in Q2 2024 and has held it in 9 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Northwestern Mutual Wealth Management held 399 shares of Axsome Therapeutics worth $97.7K as of Q2 2026.
Northwestern Mutual Wealth Management bought 12 Axsome Therapeutics shares in Q2 2026, an estimated $2.6K.
Axsome Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2289 holding.
Northwestern Mutual Wealth Management first reported a position in Axsome Therapeutics in Q2 2024 and has held it in 9 quarters since.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.